1. A10.27 Systemic Sclerosis – Role of Agonistic Autoantibodies Directed Against the Angiotensin Receptor Type 1 and the Endothelin Receptor Type A on Immune Cells in Disease Pathogenesis. (25th February 2013) Authors: Günther, J; Kill, A; Becker, MO; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diffuse myocardial fibrosis precedes impairment of myocardial strain in patients with systemic sclerosis. (13th July 2021) Authors: Gotschy, A; Jordan, S; Stoeck, CT; Von Deuster, C; Gastl, M; Vishnevskiy, V; Wissmann, L; Dobrota, R; Mihai, C; Becker, MO; Maurer, B; Kozerke, S; Ruschitzka, F; Distler, O; Manka, R Journal: European heart journal Issue: Volume 22(2021)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Responders to cyclophosphamide: results of a single-centre analysis among systemic sclerosis patients. Issue 12 (11th June 2012) Authors: Becker, MO; Schohe, A; Weinert, K; Huscher, D; Schneider, U; Burmester, GR; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 12(2012) Page Start: 2061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Systemic sclerosis – agonistic auto-antibodies directed against the angiotensin receptor type 1 and the endothelin receptor type A and their effects on immune cells. (22nd February 2011) Authors: Günther, J; Kill, A; Becker, MO; Riemekasten, G Journal: Annals of the rheumatic diseases Issue: Volume 70(2011)Supplement 2 Page Start: A33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗